1. Home
  2. NSPR vs RMI Comparison

NSPR vs RMI Comparison

Compare NSPR & RMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • RMI
  • Stock Information
  • Founded
  • NSPR 2005
  • RMI 2018
  • Country
  • NSPR United States
  • RMI United States
  • Employees
  • NSPR N/A
  • RMI N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • RMI Finance/Investors Services
  • Sector
  • NSPR Health Care
  • RMI Finance
  • Exchange
  • NSPR Nasdaq
  • RMI Nasdaq
  • Market Cap
  • NSPR 101.8M
  • RMI 88.8M
  • IPO Year
  • NSPR N/A
  • RMI N/A
  • Fundamental
  • Price
  • NSPR $2.38
  • RMI $14.58
  • Analyst Decision
  • NSPR Strong Buy
  • RMI
  • Analyst Count
  • NSPR 2
  • RMI 0
  • Target Price
  • NSPR $4.50
  • RMI N/A
  • AVG Volume (30 Days)
  • NSPR 79.2K
  • RMI 17.4K
  • Earning Date
  • NSPR 11-11-2025
  • RMI 01-01-0001
  • Dividend Yield
  • NSPR N/A
  • RMI 7.28%
  • EPS Growth
  • NSPR N/A
  • RMI N/A
  • EPS
  • NSPR N/A
  • RMI N/A
  • Revenue
  • NSPR $7,066,000.00
  • RMI N/A
  • Revenue This Year
  • NSPR $7.48
  • RMI N/A
  • Revenue Next Year
  • NSPR $104.39
  • RMI N/A
  • P/E Ratio
  • NSPR N/A
  • RMI N/A
  • Revenue Growth
  • NSPR 7.60
  • RMI N/A
  • 52 Week Low
  • NSPR $1.99
  • RMI $13.05
  • 52 Week High
  • NSPR $3.80
  • RMI $17.37
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 44.77
  • RMI 76.68
  • Support Level
  • NSPR $2.35
  • RMI $13.78
  • Resistance Level
  • NSPR $2.46
  • RMI $13.91
  • Average True Range (ATR)
  • NSPR 0.08
  • RMI 0.12
  • MACD
  • NSPR -0.00
  • RMI 0.09
  • Stochastic Oscillator
  • NSPR 23.53
  • RMI 91.95

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About RMI RiverNorth Opportunistic Municipal Income Fund Inc.

RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.

Share on Social Networks: